Nlovello, S., Scagliotti, G.V., Rosell, R., et al. (2009) Phase II Study of Continuous Daily Sunitinib Dosing in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer. Journal of Cancer, 101, 1543-1548.
非小细胞肺癌分子靶向治疗研究进展Research Progress of Molecular Target Therapy in Non-Small Cell Lung Cancer
非小细胞肺癌, 靶向治疗, 研究进展Non-Small Cell Lung Cancer, Targeted Therapy, Research Progress
《Advances in Clinical Medicine》, Vol.6 No.1, 2016-03-03
Lung cancer is a malignant tumor with high incidence rate and mortality rate. Clinically, treatment means, like surgery, radiotherapy, chemotherapy treatment, etc. are used. However, it had to admit that, besides the considerable effect for patients with early lung cancer and patients with good physique, the rising space of the treatment effect relatively limited. Lung cancer molecular target-ing therapy, compared with traditional surgery, radiotherapy and chemotherapy, due to its specific binding to the specific target of tumor cells, precisely attacking tumor cells without harm to the normal cells, has got the advantage of less toxic side effect. This new treatment modality improves patients’ life quality. This paper reviewed the research progress of drug treatment to lung cancer biological target.